Innovative Radiation Therapies—2nd Edition

Topic Information

Dear Colleagues,

With 9.6 million deaths in 2018, cancer is the second leading cause of death in the world (World Cancer Report, 2020). Each year, about 50% of all people with cancer are given radiation therapy at some point or another during their treatment. This non-invasive tool has become essential to treat tumors. Unfortunately, the conventional techniques currently used in clinics induce major side effects due to the damage caused to healthy tissues. In addition, some tumors respond poorly to conventional treatments, in particular because of their radioresistance. Therefore, there is an urgent need to re-evaluate technologies and protocols used in the clinic to develop a precision medicine approach and move towards personalized patient care.

This Topic aims to promote innovative strategies based on irradiation from new sources (high-dose rates, high LET, spatially structured beams, plasmas, etc.) and the addition of tumor-targeted nano-agents and drugs to improve the effects of radiotherapy. Strategies for treatment personalization based on artificial intelligence are also considered. This Topic is interdisciplinary and open to international experts and researchers in medical physics, radiation chemistry, and physics, focusing on numerical simulations, artificial intelligence, and developments in radiation sources, radiobiology, nanoscience, nanomedicine, plasma medicine, radiotherapy, and oncology. It is intended to give visibility to important results and ideas concerning the formulation of the next generation of secured and personalized radiotherapy treatments from the lab bench to clinical applications.

Dr. Gérard Baldacchino
Prof. Dr. Eric Deutsch
Dr. Marie Dutreix
Prof. Dr. Sandrine Lacombe
Dr. Erika Porcel
Dr. Emmanuelle Bourneuf
Dr. João Santos Sousa
Dr. Charlotte Robert
Dr. Aurélien de la Lande
Topic Editors

Keywords

Participating Journals

Journal Name	Impact Factor	CiteScore	Launched Year	First Decision (median)	APC
Cancers cancers	4.4	8.8	2009	20.3 Days	CHF 2900	Submit
Cells cells	5.2	10.5	2012	16 Days	CHF 2700	Submit
Journal of Clinical Medicine jcm	2.9	5.2	2012	17.7 Days	CHF 2600	Submit
Current Oncology curroncol	3.4	4.9	1994	21.5 Days	CHF 2200	Submit
Nanomaterials nanomaterials	4.3	9.2	2010	15.4 Days	CHF 2400	Submit
Radiation radiation	-	-	2021	25.5 Days	CHF 1000	Submit
Pharmaceutics pharmaceutics	5.5	10.0	2009	14.9 Days	CHF 2900	Submit
Applied Sciences applsci	2.5	5.5	2011	19.8 Days	CHF 2400	Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Related Topic

Published Papers